Chronic or acute, liver failure can be deadly. Toxins take over, the skin turns yellow and higher brain function slows.
“There is no effective therapy at the moment to deal with the toxins that build up in your body,” said Neil Talbot, a Research Animal Scientist for the USDA Agricultural Research Service. “Their only option now is to transplant a liver.”
Talbot thinks a line of special liver cells could change that. In an interview with the American Society of Animal Science, he discussed how a line of pig liver cells called PICM-19 could perform many of the same functions as a human liver.
In 1991, Talbot created PICM-19 from the cells of an 8-day-old pig embryo. The cell line is significant because it is “immortal,” meaning the cells can divide an infinite number of times. Many immortal cells lines continue dividing because they are derived from cancer cells; however, PICM-19 cells are derived from epiblast cells, the embryonic stem cells that form in the early stages of embryo development.
This immortal cell line has helped Talbot study how cells differentiate. Cells from the PICM-19 lines naturally differentiate into bile duct cells or hepatocytes. Hepatocytes do the bulk of the work in a liver. Hepatocytes form and secrete bile, store glycogen, control blood glucose, process vitamin D, and metabolize cholesterol and fat.
“The PICM- 19 cells are the cells that really do all the metabolic functions of the liver,” said Talbot.
Hepatocytes also “scrub” toxins from the blood. Talbot said PICM-19 cells could do the same thing inside an artificial liver. There have already been several in vitro tests of artificial liver devices, and the ARS scientists are working on ways to grow the PICM-19 cells without needing “feeder cells.” Feeder cells are mouse cells that hold PICM-19 cells in place and provide important molecules for PICM-19 cell growth and maintenance.
Artificial livers are still in development, but Talbot pointed out other applications for PICM-19 cells. Talbot and fellow scientists have used PICM-19 to study malaria, toxoplasmosis and hepatitis viruses. Researchers could also use the cells to study certain cancers of the liver or investigate the changes in the bile duct associated with cystic fibrosis.
Talbot recommends future studies on how PICM-19 cells respond to selective pressures. He said scientists could select for more efficient liver cells by exposing PICM-19 cells to toxins in culture.
“A lot of cells would die, but the survivors would really be tough,” Talbot said.
Those tougher cells could make artificial liver devices more effective. Scientists could also use genetic modification to prompt PICM-19 cells to behave like other cells in the body.
“Maybe we want to enable it to make insulin,” Talbot said. “It will be like a pancreas.”
With PICM-19 cells filling in for livers or other organs, the transplant list could get a lot shorter.
The Latest Bing News on:
- Natural Sweeteners Market To Witness Huge Growth and Revenue Acceleration by 2027on January 18, 2022 at 4:33 am
A closer look at the aspects including but not limited to Natural Sweeteners market segmentation by the end-user, end-use, geography, type, and ...
- Medivir's MIV-818 obtains the International Nonproprietary Name fostroxacitabine bralpamideon January 18, 2022 at 12:48 am
Medivir AB today announced that the World Health Organization (WHO) has selected the International Nonproprietary Name (INN) fostroxacitabine bralpamide as the official generic name for the company's ...
- The #1 Best Diet to Avoid Fatty Liver Disease, New Study Sayson January 16, 2022 at 8:01 am
New evidence suggests that sticking to this diet could help fight off a common liver condition: fatty liver disease.
- Artificial Vital Organs Market Size 2022: Global Leading Players, Comprehensive Analysis, Future Trends and Opportunities Forecast to 2026on January 11, 2022 at 12:27 am
Global “Artificial Vital Organs Market” report offers a granular analysis of the various market drivers, trends, ...
- Artificial Organs Market Manufacturers, Trend, Top Key Players, Demand, Analysis and Outlook 2027on January 9, 2022 at 11:47 pm
Emergen Research Logo Artificial Organs Market Size – USD 18.49 Billion in 2019, Market Growth - CAGR of 7.3%, Market Trends –Growing ger ...
- Hepion Pharmaceuticals Announces USAN Selection of “Rencofilstat” as Nonproprietary Name for CRV431on January 6, 2022 at 1:17 pm
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic ...
- The #1 Best Drink for Your Liver After 40on January 5, 2022 at 5:21 am
A dietitian shares which drink is best for your liver health. This drink not only helps detox but provides helpful fiber as well.
- Xylitol Warning: Artificial sweetener potentially deadly for dogs, can trigger seizures, liver failureon January 4, 2022 at 7:58 pm
I had no idea what Xylitol was.” It’s a popular artificial sweetener common in sugar free products. Xylitol is safe for humans but deadly for dogs. It can trigger seizures and liver failure. Kendra ...
- Liver transplantation an effective treatment of acute liver failure caused by Amanita verna: Studyon January 4, 2022 at 7:30 pm
Liver transplantation is an effective method for the treatment of acute liver failure caused by Amanita verna, according to a recent study published in the BMC Surgery. Amanita verna, ...
The Latest Google Headlines on:
The Latest Bing News on:
- Feed has no items.
The Latest Google Headlines on:
No news articles